from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1713/engA

LFCtreatmentdescriptionclass of inhibitor

-0.350

Amikacinug/mL Amikacintranslation

-1.672

Cap5-10ug/mL Capreomycintranslation

-0.584

Rox10-50 ug/mL Roxithromycintranslation

-0.565

SM2-5 ug/mL Streptomycintranslation

1.844

Tet5-10 ug/mL Tetracyclinetranslation

1.305

Rif0.2-5ug/mL Rifampicintranscription

0.893

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.225

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.669

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.297

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.492

Clofazimine10-13 ug/mL Clofaziminerespiration

0.067

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.584

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.734

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.554

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.076

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.203

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.833

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.321

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.520

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.240

KCN5-20 ug/mL Potassium cyaniderespiration

0.324

NaN30.2-2 mM Sodium aziderespiration

-0.788

Nigericin50 uM Nigericinrespiration

-0.128

TRC10-150 ug/mL Triclosanrespiration

-2.195

TRZ10-25 ug/mL Thioridazinerespiration

-0.941

Valinomycin0.5-10 uM Valinomycinrespiration

0.460

ZnSO42 mM ZnSO4respiration

-1.282

menadione6-10 ug/mL Menadionerespiration

-0.194

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.077

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.071

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.023

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.954

NRP_1Non-replicating persistence stage 1dosRassociated

0.385

Amp0.2mg/mL AmpicillincellWall

-0.054

Cephalexin20-100 ug/mL CephalexincellWall

-0.263

Cerulenin0.32-5 ug/mL CerulenincellWall

0.127

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.362

EMB10-20 ug/mL EthambutolcellWall

0.455

Eta12-40 ug/mL EthionamidecellWall

0.868

INH0.2-0.4 ug/mL IsoniazidcellWall

0.090

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.069

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.385

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.454

BZA0.12 mg/mL BenzamidearomaticAmides

0.219

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.711

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.938

H2O24 mM hydrogen peroxideDNAdamaging

0.534

Levo10 ug/mL LevofloxacinDNAdamaging

0.478

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.371

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.388

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.799

UVUV-irradiationDNAdamaging

-0.994

ARP41-4 ug/mL Antitubercular compound ARP4?

0.075

Antimycin12.5-50 ug/mL Antimycin A?

0.008

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.303

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.503

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.668

PA8240.2-2 ug/mL PA-824?

-0.308

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.832

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.251

Verapamil50 uM Verapamil?

-0.237

mercaptoethanol2 mM 2-Mercaptoethanol?

0.045

methoxatin10-20 ug/mL Methoxatin?